Bourla 表示即使在最严峻情景下辉瑞也能维持股息,并将恢复股息增长与约 2028 年专利悬崖期结束挂钩。
CEO Albert Bourla 曾表示,即使在公司测算的最严峻情景下,公司也能维持股息;他将恢复股息增长与专利独占期丧失阶段的结束挂钩,辉瑞称该阶段将拖累收入至 2028 年。原文 (en)
CEO Albert Bourla has said that even in the most stretched scenarios the company runs, it can maintain the dividend; he ties a return to dividend growth to the end of the loss-of-exclusivity period, which Pfizer says weighs on revenue through 2028.